Systemic lupus erythematosus diagnostic criteria: Difference between revisions
Line 14: | Line 14: | ||
!Definition | !Definition | ||
|- | |- | ||
|Clinical criteria | | rowspan="8" |Clinical criteria | ||
|Acute cutaneous lupus | |Acute cutaneous lupus | ||
| | | | ||
* Lupus malar rash | * Lupus malar rash | ||
** Fixed erythema, fl at or raised, over the malar eminences, tending to spare the nasolabial folds | |||
* Bullous lupus | * Bullous lupus | ||
* Toxic epidermal necrolysis variant of SLE | * Toxic epidermal necrolysis variant of SLE | ||
* Maculopapular lupus rash | * Maculopapular lupus rash | ||
* Photosensitive lupus rash (in the absence of dermatomyositis); | * Photosensitive lupus rash (in the absence of dermatomyositis); | ||
** Skin rash as a result of unusual reaction to sunlight, by patient history or physician observation '''OR''' | |||
* Subacute cutaneous lupus | |||
** Nonindurated psoriaform and/or annular polycyclic lesions that resolve without scarring, although occasionally with postinflammatory dyspigmentation or telangiectasias | |||
|- | |- | ||
|Chronic cutaneous lupus | |Chronic cutaneous lupus | ||
| | | | ||
Line 36: | Line 39: | ||
** Discoid lupus/lichen planus overlap | ** Discoid lupus/lichen planus overlap | ||
|- | |- | ||
|Nonscarring alopecia | |Nonscarring alopecia | ||
| | | | ||
* Diffuse thinning or hair fragility with visible broken hairs (in the absence of other causes, such as alopecia areata, drugs, iron deficiency, and androgenic alopecia) | * Diffuse thinning or hair fragility with visible broken hairs (in the absence of other causes, such as alopecia areata, drugs, iron deficiency, and androgenic alopecia) | ||
|- | |- | ||
|Oral or nasal ulcers | |Oral or nasal ulcers | ||
| | | | ||
* Palate, buccal, tongue, or nasal ulcers (in the absence of other causes, such as vasculitis, Behçet's disease, infection [herpesvirus], inflammatory bowel disease, reactive arthritis, and acidic foods) | * Palate, buccal, tongue, or nasal ulcers (in the absence of other causes, such as vasculitis, Behçet's disease, infection [herpesvirus], inflammatory bowel disease, reactive arthritis, and acidic foods) | ||
|- | |- | ||
|Joint disease | |Joint disease | ||
| | | | ||
Line 52: | Line 52: | ||
* Tenderness in two or more joints and at least 30 minutes of morning stiffness | * Tenderness in two or more joints and at least 30 minutes of morning stiffness | ||
|- | |- | ||
|Serositis | |Serositis | ||
| | | | ||
Line 58: | Line 57: | ||
* Typical pericardial pain (pain with recumbency improved by sitting forward) for more than one day, pericardial effusion, pericardial rub, or pericarditis by electrocardiography in the absence of other causes, such as infection, uremia, and Dressler's syndrome | * Typical pericardial pain (pain with recumbency improved by sitting forward) for more than one day, pericardial effusion, pericardial rub, or pericarditis by electrocardiography in the absence of other causes, such as infection, uremia, and Dressler's syndrome | ||
|- | |- | ||
|Renal | |Renal | ||
| | | | ||
Line 64: | Line 62: | ||
* Red blood cell casts | * Red blood cell casts | ||
|- | |- | ||
|Neurologic | |Neurologic | ||
| | | | ||
Line 74: | Line 71: | ||
* Acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs) | * Acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs) | ||
|- | |- | ||
|Hematologic criteria | | rowspan="6" |Hematologic criteria | ||
|Hemolytic anemia | |Hemolytic anemia | ||
| | | | ||
|- | |- | ||
|Leukopenia or lymphopenia | |Leukopenia or lymphopenia | ||
|Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), '''OR''' | |Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), '''OR''' | ||
Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection) | Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection) | ||
|- | |- | ||
|Thrombocytopenia | |Thrombocytopenia | ||
|Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura | |Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura | ||
|- | |- | ||
|ANA | |ANA | ||
|ANA level above laboratory reference range | |ANA level above laboratory reference range | ||
|- | |- | ||
|Anti-dsDNA | |Anti-dsDNA | ||
|Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA) | |Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA) | ||
|- | |- | ||
|Anit-SM | |Anit-SM | ||
|Presence of antibody to Sm nuclear antigen | |Presence of antibody to Sm nuclear antigen | ||
|- | |- | ||
|Immunologic criteria | | rowspan="3" |Immunologic criteria | ||
|Antiphospholipid | |Antiphospholipid | ||
|Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant; false-positive test result for rapid plasma reagin; medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM); or positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM) | |Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant; false-positive test result for rapid plasma reagin; medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM); or positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM) | ||
|- | |- | ||
|Low complement | |Low complement | ||
|Low C3; low C4; '''OR''' low CH50 | |Low C3; low C4; '''OR''' low CH50 | ||
|- | |- | ||
|Direct Coombs' test | |Direct Coombs' test | ||
|Direct Coombs' test in the absence of hemolytic anemia | |Direct Coombs' test in the absence of hemolytic anemia | ||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 19:03, 28 June 2017
Systemic lupus erythematosus Microchapters |
Differentiating Systemic lupus erythematosus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Systemic lupus erythematosus diagnostic criteria On the Web |
American Roentgen Ray Society Images of Systemic lupus erythematosus diagnostic criteria |
Systemic lupus erythematosus diagnostic criteria in the news |
Directions to Hospitals Treating Systemic lupus erythematosus |
Risk calculators and risk factors for Systemic lupus erythematosus diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
Diagnostic criteria
SLICC criteria for the classification of systemic lupus erythematosus
- Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997; 40:1725.
- Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677.
Criterion | Definition | |
---|---|---|
Clinical criteria | Acute cutaneous lupus |
|
Chronic cutaneous lupus |
| |
Nonscarring alopecia |
| |
Oral or nasal ulcers |
| |
Joint disease |
| |
Serositis |
| |
Renal |
| |
Neurologic |
| |
Hematologic criteria | Hemolytic anemia | |
Leukopenia or lymphopenia | Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), OR
Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection) | |
Thrombocytopenia | Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura | |
ANA | ANA level above laboratory reference range | |
Anti-dsDNA | Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA) | |
Anit-SM | Presence of antibody to Sm nuclear antigen | |
Immunologic criteria | Antiphospholipid | Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant; false-positive test result for rapid plasma reagin; medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM); or positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM) |
Low complement | Low C3; low C4; OR low CH50 | |
Direct Coombs' test | Direct Coombs' test in the absence of hemolytic anemia |